Results 81 to 90 of about 37,679 (252)
Macromolecular Materials and Engineering, EarlyView.Chewable softgels are a patient‐preferred alternative to conventional oral forms, offering pleasant taste, fast onset, and suitability for children or patients with swallowing difficulties. However, they present relevant challenges in their formulation: the shell must balance chewability, machinability, and stability, while the fill must mask the ...
Almudena Naharros‐Molinero +3 more
wiley +1 more source
Comparison of gabapentin and ketotifen in treatment of uremic pruritus in hemodialysis patients [PDF]
, 2016 Objectives: Uremic pruritus is a common problem in hemodialysis patients. Several treatments have been used for decreasing itching in these patients. Gabapentin and ketotifen are two drugs used for treating uremic patients.The aim of this study was to ...
Amirkhanlou, S. +4 more
core +1 more source
Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences [PDF]
, 2009 Background: Gabapentin and pregabalin inhibit Ca2+ currents via high-voltage-activated channels containing the α2δ-1 subunit, reducing neurotransmitter release and attenuating the postsynaptic excitability.
Carpenedo, R +5 more
core +1 more source
Managing Dystonia in Partington Syndrome
Movement Disorders Clinical Practice, EarlyView.Abstract Background Bilateral focal hand dystonia is an almost pathognomonic sign of Partington syndrome, frequently accompanied by intellectual disability and oromotor dyspraxia. However, a few studies have focused on the treatment of this focal dystonia, making patient management uncertain.
Emilie Pichon +13 more
wiley +1 more source
The Factors Influencing the Efficacy of Pregabalin Combined With Lidocaine in the Treatment of Postherpetic Neuralgia Patients: An Analysis [PDF]
Immun Inflamm DisABSTRACT Objective This study aims to analyze the primary factors influencing the therapeutic effect of pregabalin combined with lidocaine in patients with post‐herpetic neuralgia (PHN). Methods Clinical data of 97 PHN patients admitted to our hospital from January 2022 to October 2024 were retrospectively analyzed.
Wang X, Cong W, Jin J, Zhao L.
europepmc +2 more sources
Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences [PDF]
Pregabalin is currently approved for the treatment of epilepsy, generalized anxiety disorder, neuropathic pain, and fibromyalgia. A qualitative study was undertaken in Jordan, where concerns have been raised about its unprescribed availability in ...
van Hout, MC
core +1 more source
Intrapatient variability of the pupillary pain index to remifentanil [PDF]
, 2017 info:eu-repo/semantics ...
Amorim, Pedro +6 more
core +1 more source
Movement Disorders, EarlyView.Abstract Background The first International Parkinson and Movement Disorder Society Evidence‐Based Medicine (MDS‐EBM) review for essential tremor (ET) was published in 2019; since then, the modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was adopted by MDS, and new evidence exists.
Deepa Dash +12 more
wiley +1 more source
Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome
Neurobiology of Disease, 2011 Pregabalin, a Ca2+ channel α2δ-subunit antagonist with analgesic and antiepileptic activity, reduced neuronal loss and improved functional outcome in a mouse model of focal ischemic stroke.
Jeong Seon Yoon +5 more
doaj +1 more source
Pregabalin induced visual hallucinations – a rare adverse reaction
BMC Pharmacology and Toxicology, 2020 Background Pregabalin is an anticonvulsive, analgesic and anxiolytic medication. The typical side effects include dizziness, somnolence and weight gain. Few studies or case reports have demonstrated psychiatric side effects resulting from its use.
Georgios Mousailidis +4 more
doaj +1 more source